Yao J, Yao W, Zhu J, Liu Y, Liu J, Ji Y
Adv Sci (Weinh). 2024; 12(1):e2411042.
PMID: 39513253
PMC: 11714213.
DOI: 10.1002/advs.202411042.
Gholami M, Coleman-Fuller N, Salehirad M, Darbeheshti S, Motaghinejad M
Int J Prev Med. 2024; 15:28.
PMID: 39239308
PMC: 11376549.
DOI: 10.4103/ijpvm.ijpvm_5_23.
Bautista-Elivar N, Aviles-Trigueros M, Bueno J
Int J Mol Sci. 2024; 25(16).
PMID: 39201444
PMC: 11354294.
DOI: 10.3390/ijms25168756.
Tang H, Li J, Yuan Y, Ling Y, Mei Z, Zou H
PLoS One. 2024; 19(7):e0305573.
PMID: 38985778
PMC: 11236136.
DOI: 10.1371/journal.pone.0305573.
Zhang X, Zhang F, Xu X
Clin Transl Med. 2024; 14(7):e1751.
PMID: 38946005
PMC: 11214886.
DOI: 10.1002/ctm2.1751.
Cellular and Molecular Mechanisms of Neuronal Degeneration in Early-Stage Diabetic Retinopathy.
Callan A, Jha S, Valdez L, Tsin A
Curr Vasc Pharmacol. 2024; 22(5):301-315.
PMID: 38693745
DOI: 10.2174/0115701611272737240426050930.
Modeling early pathophysiological phenotypes of diabetic retinopathy in a human inner blood-retinal barrier-on-a-chip.
Maurissen T, Spielmann A, Schellenberg G, Bickle M, Vieira J, Lai S
Nat Commun. 2024; 15(1):1372.
PMID: 38355716
PMC: 10866954.
DOI: 10.1038/s41467-024-45456-z.
The ideal treatment timing for diabetic retinopathy: the molecular pathological mechanisms underlying early-stage diabetic retinopathy are a matter of concern.
Sun W, An X, Zhang Y, Zhao X, Sun Y, Yang C
Front Endocrinol (Lausanne). 2023; 14:1270145.
PMID: 38027131
PMC: 10680169.
DOI: 10.3389/fendo.2023.1270145.
Activated cGAS/STING signaling elicits endothelial cell senescence in early diabetic retinopathy.
Liu H, Ghosh S, Vaidya T, Bammidi S, Huang C, Shang P
JCI Insight. 2023; 8(12).
PMID: 37345657
PMC: 10371250.
DOI: 10.1172/jci.insight.168945.
Inhibition of Galectins and the P2X7 Purinergic Receptor as a Therapeutic Approach in the Neurovascular Inflammation of Diabetic Retinopathy.
Lepre C, Russo M, Trotta M, Petrillo F, DAgostino F, Gaudino G
Int J Mol Sci. 2023; 24(11).
PMID: 37298672
PMC: 10253913.
DOI: 10.3390/ijms24119721.
The retina-specific basigin isoform does not induce IL-6 expression in mouse monocytes.
Solstad A, Brown J, Ochrietor J
Mol Vis. 2023; 29:13-24.
PMID: 37287642
PMC: 10243675.
Elucidating glial responses to products of diabetes-associated systemic dyshomeostasis.
Padovani-Claudio D, Ramos C, Capozzi M, Penn J
Prog Retin Eye Res. 2023; 94:101151.
PMID: 37028118
PMC: 10683564.
DOI: 10.1016/j.preteyeres.2022.101151.
MicroRNA-150 (miR-150) and Diabetic Retinopathy: Is miR-150 Only a Biomarker or Does It Contribute to Disease Progression?.
Ko G, Yu F, Bayless K, Ko M
Int J Mol Sci. 2022; 23(20).
PMID: 36292956
PMC: 9603433.
DOI: 10.3390/ijms232012099.
Neuroprotective Effect of Azithromycin Following Induction of Optic Nerve Crush in Wild Type and Immunodeficient Mice.
Zloto O, Zahavi A, Richard S, Friedman-Gohas M, Weiss S, Goldenberg-Cohen N
Int J Mol Sci. 2022; 23(19).
PMID: 36233171
PMC: 9570389.
DOI: 10.3390/ijms231911872.
mTOR Signalling Pathway: A Potential Therapeutic Target for Ocular Neurodegenerative Diseases.
Wang Y, Fung N, Lam W, Lo A
Antioxidants (Basel). 2022; 11(7).
PMID: 35883796
PMC: 9311918.
DOI: 10.3390/antiox11071304.
Biochemical mechanism underlying the pathogenesis of diabetic retinopathy and other diabetic complications in humans: the methanol-formaldehyde-formic acid hypothesis.
Zhu B
Acta Biochim Biophys Sin (Shanghai). 2022; 54(4):415-451.
PMID: 35607958
PMC: 9828688.
DOI: 10.3724/abbs.2022012.
Involvement of High Mobility Group Box 1 Protein in Optic Nerve Damage in Diabetes.
Mohammad G, Kowluru R
Eye Brain. 2022; 14:59-69.
PMID: 35586662
PMC: 9109986.
DOI: 10.2147/EB.S352730.
Retinal Src homology region 2-containing protein tyrosine phosphatase 2 silencing alleviates diabetic retinopathy via suppressing inflammatory response and oxidative stress by regulating Yes-associated protein 1 activity.
Han N, Su Y, Guo M, Yu L
Exp Anim. 2022; 71(3):376-384.
PMID: 35400714
PMC: 9388342.
DOI: 10.1538/expanim.21-0122.
Enhancing fractalkine/CX3CR1 signalling pathway can reduce neuroinflammation by attenuating microglia activation in experimental diabetic retinopathy.
Jiang M, Xie H, Zhang C, Wang T, Tian H, Lu L
J Cell Mol Med. 2022; 26(4):1229-1244.
PMID: 35023309
PMC: 8831940.
DOI: 10.1111/jcmm.17179.
Hyperreflective Foci and Subretinal Fluid Are Potential Imaging Biomarkers to Evaluate Anti-VEGF Effect in Diabetic Macular Edema.
Qin S, Zhang C, Qin H, Xie H, Luo D, Qiu Q
Front Physiol. 2022; 12:791442.
PMID: 35002773
PMC: 8733589.
DOI: 10.3389/fphys.2021.791442.